Engagement & communication

We make environmental risk data for our existing products publicly available via the Swedish Doctors Prescribing Guide website (available only in Swedish at this time), using the voluntary disclosure system introduced by the Swedish Association of the Pharmaceutical Industry (LIF).  AstraZeneca has a leading role in developing the guidance for this activity.

We collaborate with other pharmaceutical companies, non-governmental organisations, scientists, regulators, patients, and prescribers to answer questions and manage issues on this topic responsibly, consistent with current scientific knowledge.

We continue to share our research by regularly publishing scientific papers in peer-reviewed journals.  Some of our work is shown in the bibliography.